fairview health limited Company Information
Company Number
06907366
Website
www.fairview.orgRegistered Address
3 hobbs house, harrovian business village, bess, harrow, middlesex, HA1 3EX
Industry
Wholesale of pharmaceutical goods
Telephone
02070183770
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
fairview group (uk) limited 100%
fairview health limited Estimated Valuation
Pomanda estimates the enterprise value of FAIRVIEW HEALTH LIMITED at £12.6m based on a Turnover of £15m and 0.84x industry multiple (adjusted for size and gross margin).
fairview health limited Estimated Valuation
Pomanda estimates the enterprise value of FAIRVIEW HEALTH LIMITED at £0 based on an EBITDA of £-2.6m and a 6.59x industry multiple (adjusted for size and gross margin).
fairview health limited Estimated Valuation
Pomanda estimates the enterprise value of FAIRVIEW HEALTH LIMITED at £8.4m based on Net Assets of £4m and 2.11x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Fairview Health Limited Overview
Fairview Health Limited is a live company located in harrow, HA1 3EX with a Companies House number of 06907366. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in May 2009, it's largest shareholder is fairview group (uk) limited with a 100% stake. Fairview Health Limited is a established, mid sized company, Pomanda has estimated its turnover at £15m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Fairview Health Limited Health Check
Pomanda's financial health check has awarded Fairview Health Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 3 areas for improvement. Company Health Check FAQs
7 Strong
2 Regular
3 Weak
Size
annual sales of £15m, make it smaller than the average company (£25.8m)
- Fairview Health Limited
£25.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 14%, show it is growing at a faster rate (4.4%)
- Fairview Health Limited
4.4% - Industry AVG
Production
with a gross margin of 26.3%, this company has a comparable cost of product (26.3%)
- Fairview Health Limited
26.3% - Industry AVG
Profitability
an operating margin of -18% make it less profitable than the average company (4%)
- Fairview Health Limited
4% - Industry AVG
Employees
with 52 employees, this is above the industry average (38)
52 - Fairview Health Limited
38 - Industry AVG
Pay Structure
on an average salary of £72.2k, the company has an equivalent pay structure (£72.2k)
- Fairview Health Limited
£72.2k - Industry AVG
Efficiency
resulting in sales per employee of £287.7k, this is less efficient (£627.3k)
- Fairview Health Limited
£627.3k - Industry AVG
Debtor Days
it gets paid by customers after 47 days, this is earlier than average (59 days)
- Fairview Health Limited
59 days - Industry AVG
Creditor Days
its suppliers are paid after 60 days, this is slower than average (29 days)
- Fairview Health Limited
29 days - Industry AVG
Stock Days
it holds stock equivalent to 13 days, this is less than average (66 days)
- Fairview Health Limited
66 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 46 weeks, this is more cash available to meet short term requirements (12 weeks)
46 weeks - Fairview Health Limited
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 36.7%, this is a lower level of debt than the average (56.5%)
36.7% - Fairview Health Limited
56.5% - Industry AVG
FAIRVIEW HEALTH LIMITED financials
Fairview Health Limited's latest turnover from December 2022 is estimated at £15 million and the company has net assets of £4 million. According to their latest financial statements, Fairview Health Limited has 52 employees and maintains cash reserves of £2.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 52 | 45 | 37 | 27 | 13 | 9 | 9 | 7 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 230,174 | 70,433 | 99,662 | 63,529 | 5,498 | 30,024 | 43,557 | 65,335 | 69,380 | 5,118 | 10,236 | 15,354 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 230,174 | 70,433 | 99,662 | 63,529 | 5,498 | 30,024 | 43,557 | 65,335 | 69,380 | 5,118 | 10,236 | 15,354 | 0 | 0 |
Stock & work in progress | 408,821 | 480,946 | 439,703 | 581,957 | 546,618 | 388,378 | 262,945 | 58,354 | 44,398 | 62,710 | 19,670 | 16,929 | 19,470 | 0 |
Trade Debtors | 1,957,160 | 2,015,428 | 1,419,898 | 1,726,045 | 1,009,907 | 1,026,772 | 1,104,550 | 553,651 | 333,547 | 167,020 | 70,556 | 115,295 | 133,490 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 1,286,939 | 843,350 | 144,915 | 53,710 | 147,694 | 0 | 78,665 | 11,463 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 2,081,383 | 6,591,508 | 5,258,341 | 3,100,162 | 2,320,955 | 2,187,692 | 827,235 | 399,439 | 689,698 | 532,895 | 438,570 | 238,042 | 279,866 | 0 |
misc current assets | 355,000 | 240,000 | 240,000 | 240,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 6,089,303 | 10,171,232 | 7,502,857 | 5,701,874 | 4,025,174 | 3,602,842 | 2,273,395 | 1,022,907 | 1,067,643 | 762,625 | 528,796 | 370,266 | 432,826 | 0 |
total assets | 6,319,477 | 10,241,665 | 7,602,519 | 5,765,403 | 4,030,672 | 3,632,866 | 2,316,952 | 1,088,242 | 1,137,023 | 767,743 | 539,032 | 385,620 | 432,826 | 0 |
Bank overdraft | 0 | 0 | 0 | 868 | 2,226 | 1,062 | 483 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 1,836,413 | 2,583,427 | 1,738,734 | 1,256,232 | 1,051,220 | 626,554 | 777,236 | 191,103 | 764,921 | 364,753 | 250,427 | 153,429 | 212,059 | 0 |
Group/Directors Accounts | 0 | 20,000 | 33,120 | 53,120 | 0 | 0 | 0 | 202,575 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 484,910 | 1,093,526 | 1,012,418 | 957,080 | 673,930 | 903,008 | 548,763 | 38,425 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 2,321,323 | 3,696,953 | 2,784,272 | 2,267,300 | 1,727,376 | 1,530,624 | 1,326,482 | 432,103 | 764,921 | 364,753 | 250,427 | 153,429 | 212,059 | 0 |
loans | 0 | 0 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 2,321,323 | 3,696,953 | 2,834,272 | 2,267,300 | 1,727,376 | 1,530,624 | 1,326,482 | 432,103 | 764,921 | 364,753 | 250,427 | 153,429 | 212,059 | 0 |
net assets | 3,998,154 | 6,544,712 | 4,768,247 | 3,498,103 | 2,303,296 | 2,102,242 | 990,470 | 656,139 | 372,102 | 402,990 | 288,605 | 232,191 | 220,767 | 0 |
total shareholders funds | 3,998,154 | 6,544,712 | 4,768,247 | 3,498,103 | 2,303,296 | 2,102,242 | 990,470 | 656,139 | 372,102 | 402,990 | 288,605 | 232,191 | 220,767 | 0 |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 102,302 | 41,610 | 39,977 | 23,010 | 24,526 | 24,526 | 21,778 | 21,778 | 5,118 | 5,118 | 5,118 | 5,118 | 0 | |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Tax | ||||||||||||||
Stock | -72,125 | 41,243 | -142,254 | 35,339 | 158,240 | 125,433 | 204,591 | 13,956 | -18,312 | 43,040 | 2,741 | -2,541 | 19,470 | 0 |
Debtors | 385,321 | 1,293,965 | -214,942 | 622,154 | 130,829 | -156,443 | 618,101 | 231,567 | 166,527 | 96,464 | -44,739 | -18,195 | 133,490 | 0 |
Creditors | -747,014 | 844,693 | 482,502 | 205,012 | 424,666 | -150,682 | 586,133 | -573,818 | 400,168 | 114,326 | 96,998 | -58,630 | 212,059 | 0 |
Accruals and Deferred Income | -608,616 | 81,108 | 55,338 | 283,150 | -229,078 | 354,245 | 510,338 | 38,425 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | -20,000 | -13,120 | -20,000 | 53,120 | 0 | 0 | -202,575 | 202,575 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | -50,000 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -4,510,125 | 1,333,167 | 2,158,179 | 779,207 | 133,263 | 1,360,457 | 427,796 | -290,259 | 156,803 | 94,325 | 200,528 | -41,824 | 279,866 | 0 |
overdraft | 0 | 0 | -868 | -1,358 | 1,164 | 579 | 483 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -4,510,125 | 1,333,167 | 2,159,047 | 780,565 | 132,099 | 1,359,878 | 427,313 | -290,259 | 156,803 | 94,325 | 200,528 | -41,824 | 279,866 | 0 |
fairview health limited Credit Report and Business Information
Fairview Health Limited Competitor Analysis
Perform a competitor analysis for fairview health limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
fairview health limited Ownership
FAIRVIEW HEALTH LIMITED group structure
Fairview Health Limited has no subsidiary companies.
fairview health limited directors
Fairview Health Limited currently has 2 directors. The longest serving directors include Mr Jawad Merali (Feb 2019) and Mr Riazali Esmail (Feb 2019).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Jawad Merali | England | 42 years | Feb 2019 | - | Director |
Mr Riazali Esmail | England | 66 years | Feb 2019 | - | Director |
P&L
December 2022turnover
15m
-8%
operating profit
-2.7m
0%
gross margin
26.3%
-1.13%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
4m
-0.39%
total assets
6.3m
-0.38%
cash
2.1m
-0.68%
net assets
Total assets minus all liabilities
fairview health limited company details
company number
06907366
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
May 2009
age
15
accounts
Small Company
ultimate parent company
previous names
N/A
incorporated
UK
address
3 hobbs house, harrovian business village, bess, harrow, middlesex, HA1 3EX
last accounts submitted
December 2022
fairview health limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to fairview health limited.
fairview health limited Companies House Filings - See Documents
date | description | view/download |
---|